Nature Biotechnology
Close windowclose window
Figure 1

Nature Biotechnology  19, 66 - 70 (2001)
doi:10.1038/83540

Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice

David E. Kerr, Karen Plaut, A. John Bramley, Christine M. Williamson, Alistair J. Lax, Karen Moore, Kevin D. Wells & Robert J. Wall
mastitisanimal biotechnologyantibacterial proteinStaphylococcus aureus
 
Fig 1 full size
Figure 1. Western blot analysis of lysostaphin production by transfected COS-7 cells.
(A) Construct map of cytosolically directed, native lysostaphin (Cyto-Lys). (B) Construct map of secreted, native lysostaphin (Sec-Lys). (C) Construct map of secreted, Gln125,232-lysostaphin (Sec-Gln125,232 -Lys). Proteins in cell extracts (D) or medium (E) were probed with anti-lysostaphin antiserum. Lane 1, bacterial lysostaphin (100 ng/ml). Lanes 2−5: Cells were transfected with plasmids containing the CMV promoter driving expression of hGH (lane 2), Cyto-Lys (lane 3), Sec-Lys (lane 4), or Sec-Gln125,232-Lys (lane 5).

 
Next 
Close windowclose window
©2007 Nature Publishing Group | Privacy policy